IDH1-R132H acts as a tumor suppressor in glioma via epigenetic up-regulation of the DNA damage response
2019 · Science Translational Medicine · 283 citations
https://doi.org/10.1126/scitranslmed.aaq1427
C
Carl Koschmann
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
479
Papers
4.5K
Citations
37
h-index
81
i10-index
Carl Koschmann is an academic researcher. The author has contributed to research in topics: Glioma Diagnosis and Treatment & Cancer, Hypoxia, and Metabolism & ATP Synthase and ATPases Research. The author has an h-index of 37, co-authored 408 publications.
ORCID: 0000-0002-0825-7615Papers by this author
worksMechanisms of Glioma Formation: Iterative Perivascular Glioma Growth and Invasion Leads to Tumor Progression, VEGF-Independent Vascularization, and Resistance to Antiangiogenic Therapy
2014 · Neoplasia · 154 citations
https://doi.org/10.1016/j.neo.2014.06.003
TIM-3 blockade in diffuse intrinsic pontine glioma models promotes tumor regression and antitumor immune memory
2023 · Cancer Cell · 88 citations
https://doi.org/10.1016/j.ccell.2023.09.001
ATRX loss in glioma results in dysregulation of cell-cycle phase transition and ATM inhibitor radio-sensitization
2022 · Cell Reports · 70 citations
https://doi.org/10.1016/j.celrep.2021.110216
Phase I dose escalation and expansion trial of single agent ONC201 in pediatric diffuse midline gliomas following radiotherapy
2022 · Neuro-Oncology Advances · 56 citations
https://doi.org/10.1093/noajnl/vdac143
GABAergic neuronal lineage development determines clinically actionable targets in diffuse hemispheric glioma, H3G34-mutant
2024 · Cancer Cell · 40 citations
https://doi.org/10.1016/j.ccell.2024.08.006
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat